查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387352

恐慌症市场报告：2030 年趋势、预测与竞争分析

Panic Disorders Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

恐慌症趋势与预测

预计 2024 年至 2030 年，全球恐慌症市场将以 7.8% 的复合年增长率成长。这个市场的主要驱动因素是受恐慌症影响的患者数量不断增加，以及人们对心理健康的认识和配合措施不断提高。全球恐慌症市场的未来前景看好，医院、精神卫生保健中心和精神病院市场存在商机。

恐慌症市场洞察

Lucintel 预测，锭剂将继续占据很大一部分市场，因为它们能够帮助减少恐慌发作的频率和严重程度。

在这个市场中，精神健康保健中心将继续成为最大的部分，因为它们提供广泛的服务，包括个人和团体治疗、药物管理和危机干预。

由于人们对心理健康的认识不断提高以及拥有高度发展的医疗基础设施，北美在预测期内可能仍是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球恐慌症市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球恐慌症市场趋势（2018-2023）与预测（2024-2030）
  • 全球恐慌症市场（按剂量）
    • 锭剂
    • 注射
    • 其他的
  • 按类型分類的全球恐慌症市场
    • 恐惧症
    • 社交恐惧症
    • 强迫性精神官能症
    • 躁郁症
    • 创伤后压力症候群（PTSD）
    • 特定恐惧症
    • 整体焦虑症
    • 重度忧郁症
  • 以最终用途分類的全球恐慌症市场
    • 医院
    • 精神保健中心
    • 精神病院
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球恐慌症市场
  • 北美恐慌症市场
  • 欧洲恐慌症市场
  • 亚太恐慌症市场
  • 其他地区恐慌症市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球恐慌症市场成长机会（按剂量）
    • 按类型分類的全球恐慌症市场成长机会
    • 按最终用途分類的全球恐慌症市场成长机会
    • 按地区分類的全球恐慌症市场成长机会
  • 全球恐慌症市场新趋势
  • 战略分析
    • 新产品开发
    • 全球恐慌症市场容量扩张
    • 全球恐慌症收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • AstraZeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
简介目录

Panic Disorders Trends and Forecast

The future of the global panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

A more than 150-page report is developed to help in your business decisions.

Panic Disorders by Segment

The study includes a forecast for the global panic disorders by dosage, type, end use, and region.

Panic Disorders Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Injections
  • Others

Panic Disorders Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Agoraphobia
  • Social Anxiety Disorder
  • Obsessive-Compulsive Disorder
  • Bipolar Disorder
  • Post-Traumatic Stress Disorder
  • Specific Phobias
  • Generalized Anxiety Disorder
  • Major Depressive Disorder

Panic Disorders Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Mental Healthcare Centres
  • Asylums
  • Others

Panic Disorders Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Panic Disorders Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies panic disorders companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the panic disorders companies profiled in this report include-

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Panic Disorders Market Insights

Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Within this market, mental healthcare center will remain the largest segment as it delivers wide range of services, such as individual and group therapy, medication management, and crisis intervention.

North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Features of the Global Panic Disorders Market

Market Size Estimates: Panic disorders market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Panic disorders market size by dosage, type, end use, and region in terms of value ($B).

Regional Analysis: Panic disorders market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, types, end uses, and regions for the panic disorders market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the panic disorders market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for panic disorders market?

Answer: The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the panic disorders market?

Answer: The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

Q3. What are the major segments for panic disorders market?

Answer: The future of the panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets.

Q4. Who are the key panic disorders market companies?

Answer: Some of the key panic disorders companies are as follows:

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Q5. Which panic disorders market segment will be the largest in future?

Answer: Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Q6. In panic disorders market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the panic disorders market by dosage (tablets, injections, and others), type (agoraphobia, social anxiety disorder, obsessive-compulsive disorder, bipolar disorder, post-traumatic stress disorder, specific phobias, generalized anxiety disorder, and major depressive disorder), end use (hospitals, mental healthcare centres, asylums, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Panic Disorders Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Panic Disorders Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Panic Disorders Market by Dosage
    • 3.3.1: Tablets
    • 3.3.2: Injections
    • 3.3.3: Others
  • 3.4: Global Panic Disorders Market by Type
    • 3.4.1: Agoraphobia
    • 3.4.2: Social Anxiety Disorder
    • 3.4.3: Obsessive-Compulsive Disorder
    • 3.4.4: Bipolar Disorder
    • 3.4.5: Post-Traumatic Stress Disorder
    • 3.4.6: Specific Phobias
    • 3.4.7: Generalized Anxiety Disorder
    • 3.4.8: Major Depressive Disorder
  • 3.5: Global Panic Disorders Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Mental Healthcare Centres
    • 3.5.3: Asylums
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Panic Disorders Market by Region
  • 4.2: North American Panic Disorders Market
    • 4.2.2: North American Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.3: European Panic Disorders Market
    • 4.3.1: European Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.3.2: European Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.4: APAC Panic Disorders Market
    • 4.4.1: APAC Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.4.2: APAC Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.5: ROW Panic Disorders Market
    • 4.5.1: ROW Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.5.2: ROW Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Panic Disorders Market by Dosage
    • 6.1.2: Growth Opportunities for the Global Panic Disorders Market by Type
    • 6.1.3: Growth Opportunities for the Global Panic Disorders Market by End Use
    • 6.1.4: Growth Opportunities for the Global Panic Disorders Market by Region
  • 6.2: Emerging Trends in the Global Panic Disorders Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Panic Disorders Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Panic Disorders Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Teva Pharmaceutical Industries
  • 7.2: Sun Pharmaceutical Industries
  • 7.3: Mylan
  • 7.4: AstraZeneca
  • 7.5: Abbott
  • 7.6: Baxter
  • 7.7: Bristol-Myers Squibb Company
  • 7.8: Eli Lilly and Company
  • 7.9: F. Hoffmann-La Roche
  • 7.10: GlaxoSmithKline